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Abstract
Background: Rotaviruses are the major cause of diarrhea among the infants and young children all over the world
causing over 500,000 deaths and 2.4 million hospitalizations each year. In Nepal Rotavirus infection positivity rates
ranges from 17.0 to 39.0% among children less than 5 years. However, little is known about the molecular genotypes
of Rotavirus prevailing. The objective of this study was to estimate the burden of Rotavirus gastroenteritis and
determine the genotypes of Rotavirus among children less than 5 years.
Methods: The cross sectional study was conducted from January to November 2014 among children less than 5 years
old visiting Kanti Children’s Hospital and Tribhuvan University Teaching Hospital.
Rotavirus antigen detection was performed by Enzyme Linked Immunosorbent Assay (ELISA) using ProSpecT Rotavirus
Microplate Assay. Among the Rotavirus antigen positive samples, 59 samples were used for Rotavirus RNA extraction.
Multiplex PCR was performed to identify G type comprising G1-G4, G8-G10 and G12 and P type comprising P[4], P[6],
P[8], P[9], P[10], and P[11].
Results: A total of 717 diarrheal stool samples were collected from patients ranging from 10 days to 59 months of age.
Rotavirus antigen positive was found among (N = 164)22.9% of patients. The highest number of the diarrhea was seen in
January. Molecular analysis of Rotavirus genotypes revealed that the predominant G-Type was G12 (36%) followed by G9
(31%), G1 (21%), G2 (8.6%). The predominant P- type was P6 (32.8%) followed by P8 (31%), P10 (14.8%), P4 (14.8%). A total
of seven G/P type combinations were identified the most common being G12P [6] (35.8%), G1P [8] (15.1%), G9P [8] (15.
1%).
Conclusion: Rotavirus diarrhea is, mostly affecting children from 7 to 24 months in Nepal, mostly occurring in winter. The
circulating genotypes in the country are found to be primarily unusual genotypes and predominance of G12P[6]. It is
recommended to conduct genotyping of Rotavirus on large samples before starting vaccination in the country.
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Background
Rotaviruses are non-enveloped, double stranded RNA
viruses with 11 gene segments under Reoviridae
family having seven major groups (A-G) [1]. Group A
Rotaviruses are the major causes of diarrhea among
the infants and young children all over the world [2]
causing over 500,000 deaths and 2.4 million hospitali-
zations each year [3]. The virus is composed of three
concentric layers; the outermost shell contains VP7 or
G protein and VP4 or P protein, which are able to
produce neutralizing antibodies during infection of a
host [1]. Such neutralizing antibodies are the basis of
dual classification of group A rotaviruses into G and
P types. With the advent of molecular techniques
(Reverse transcriptase, RT-PCR), classification into G
and P type on the basis of genes encoding the G and
P proteins has become widely accepted standard
technique [4].
Virtually every child around the globe experiences
Rotavirus diarrhea by the age of 3–5 years [2]. The
higher standards of living style, good hygiene and proper
sanitation followed in developed countries are not
merely sufficient to prevent Rotavirus diarrhea. Although
the incidence of diarrhea is similar in developed and
developing countries, the Rotavirus diarrhea differs char-
acteristically between them, in developing countries the
severity as well as mortality is very high, many strains
occur at a time and disease occurs at early age [5]. In
addition, in developing countries diarrhea results in a
deadly cycle of malnourishment and diarrhea [6].
With no availability of antivirals, vaccines are hoped to
prevent disease, reduce morbidity and mortality of the
disease. World Health Organization (WHO) has recom-
mended the inclusion of Rotavirus vaccination of infants
into all national immunization programs [7]. Eighty four
countries including 36 low income countries have
introduced Rotavirus vaccination and global coverage is
estimated to be 23%. Although the efficacy of oral vaccines
in developing countries, in presence of other enteric
infections, was dubious; recent data shows vaccination was
successful in substantially reducing severe diarrhea and/or
rotavirus disease [8]. However, Rotavirus vaccination has
not been included in national immunization program in
Nepal. And studies on Rotavirus infection from 1999 to
2007 showed positivity rates ranging from 17.0 to 39.0%
among children less than 5 years [9].
Globally, G1, G2, G3, and G4 constitute more than
88.5% of globally identified strains [5]. At odds with
global scenario, the most frequently reported G types
included G12, G1, G2, G9 from Nepal [10–13]. The first
description of G12 rotaviruses dates back to the
1990s from Philippines which were characterized
serologically and by nucleotide sequencing as
G12P[4]. Beginning in 2002, reports of the detection
and increased prevalence of G12 strains have
appeared from Asia (Thailand, India, Korea, Japan,
Bangladesh, Nepal, and Saudi Arabia) and the America
(the United States, Argentina, and Brazil) [14].
There are regional and geographical differences as well
as difference over time in same region in strain distribu-
tion [7]. The enormous diversity of Rotavirus is mainly
because of point mutations, genetic reassortment or intro-
duction of animal viral strains to human beings [15].
Therefore, rotavirus surveillance is needed to monitor the
prevalence and possible changes of the different G and P
types circulating in the region.
The study was conducted to estimate the burden of
Rotavirus gastroenteritis as well as genotype of rotavirus
among children less than 5 years of age visiting national
level children hospitals, Kanti Children’s Hospital and
Tribhuvan University Teaching Hospital.
Methods
The cross sectional study was conducted from January to
November 2014 among children less than 5 years of age
visiting national level children hospitals, Kanti Children’s
Hospital and Tribhuvan University Teaching Hospital.
These both hospitals are situated in Kathmandu city, cap-
ital of Nepal. These are among the largest hospitals of the
country. Kanti Children’s Hospital is only central/national
pediatric hospital of the country.
Seven hundred seventeen single diarrheal stool speci-
mens were collected from children with acute diarrhea
who were referred to the observation ward and who
were admitted to the hospital for not more than 3 days.
The 10–20% suspensions of the specimens were made
using phosphate buffered saline for antigen testing and
genotyping in different vials and stored at −20 °C.
Stool samples were initially tested for group A Rotavirus
antigen using ProSpecT Rotavirus enzyme immune assay
(Oxoid Ltd., Basingstoke Hants, UK) and subsequently
random 59 Rotavirus antigen positive samples were
selected for RNA extraction using the commercial
QIAamp Viral RNA Mini Kit (QIAGEN Inc). The tests
were performed as specified by manufacturer.
RT PCR
The extracted dsRNA was converted to cDNA as
described by Gouvea et al. [16]. The formed cDNA was
used for subsequent PCR reactions.
Typing by multiplex PCR
G–Typing
The first round of G type PCR was targeted to gene
segment 9. Amplification of the fragment was performed
with primers, VP7-F (5’ATG TAT GGT ATT GAA TAT
ACC AC3′) and VP7-R (5’AAC TTG CCA CCA TTT
TTT 3′) in a 50 μl of a PCR mixture (5 U Taq DNA
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polymerase; 10 mM each dNTP’s; 50 mM MgCl2;
20 pmol of each primer; 10X buffer). The second round,
a multiplex PCR was designed to identify the genotypes
G1-G4, G8-G10 and G12 [12, 17].
P-Typing
The first round of P type PCR was targeted to gene seg-
ment 4. Amplification of fragment was performed with
primers, VP4-F (5’TAT GCT CCA GTN AAT TGG3’)
and VP4-R (5’ATT GCA TTT CTT TCC ATA ATG 3’)
in a 50 μl of a PCR mixture (5 U Taq DNA polymerase;
10 mM each dNTP’s; 50 mM MgCl2; 20 pmol of each
primer; 10X buffer) The second round, a multiplex PCR
was designed to identify the genotypes P[4], P[6], P[8],
P[9], P[10], and P[11] [18].
Results
Seven hundred and seventeen patients less than 5 years
of age were enrolled in the study with age from 10 days
to 59 months. The highest number of patients (N = 341)
belonged to age group 0–12 months followed by
(N = 202) 13–24 months. In total there were 475
(66.2%) males and 242(33.8%) females. The dataset gen-
erated during the study are available in the data_diarrhea
repository within the Additional file 1.
Occurrence of Rotavirus diarrhea
All samples were examined for Rotavirus using ELISA.
The ELISA of Rotavirus antigen was found to be positive
among 22.9% (N = 164) of the isolates.
Monthly occurrence of Rotavirus diarrhea
The highest number of rotaviral diarrhea (N = 30) was
seen in January followed by (N = 26) in February as
shown in Fig. 1.
Age wise distribution of Rotavirus ELISA result
The highest number of Rotavirus positive diarrheal pa-
tients was detected on 0–12 month age group category
which accounted 56.0% of total Rotavirus positive samples
as shown in Table 1.
Distribution of G-Type of Rotavirus
Molecular analysis of Rotavirus genotypes revealed that
the predominant G-Type was G12 (n = 21, 36%)
followed by G9 (n = 18, 31%), G1 (n = 11, 21%), G2
(n = 5, 8.6%). Out of five G-types, G3 (n = 4) was least
found genotype representing 3.4%, while 1.8% was found
to be untypable.
The genotype was determined according to the
electrophoresis of the product which differed according
to the basis base pairs as shown in Fig. 2.
Distribution of P-Type of Rotavirus
Molecular analysis of Rotavirus genotypes revealed that
the predominant P-type was P[6] (n = 19, 32.8%)
followed by P[8] (n = 17,31%), P[10] (n = 1014.8%), P[4]
(n = 9, 14.8%). Similarly, 6.6% of isolates were found to
be untypable.
Genotypic distribution of Rotavirus
In total seven G/P type combinations were identified, in-
cluding G12P[6] (35.8%), G1P[8] (15.1%), G9P[8] (15.1%)
which was the most commonly detected Rotavirus strain
type, followed by G9P[4] (9.4%), G2P[4] (7.5%). (Table 2).
Discussion
The Rotavirus antigen positive was found among 22.9% of
the isolates in the study similar to other studies in Nepal;
25.9% by Ansari [19] et al., 17% by Uchida R [20] et al.
and 33% by Sherchand et al. [13]. The incidence rate is
comparable to the reports from India, Malaysia, Japan and
Taiwan (20–25%) but much lower than Thailand,
Myanmar and Vietnam (38.1–56%) [21]. These higher
prevalence countries also relied on similar method of
detection i.e. Enzyme immunoassay of Rotavirus antigen,
the higher incidence rate in these countries is ascribed to
low occurrence of other etiology (bacteria) of diarrhea,
increased level of economic standards, proper water
supply and good hygiene.
Fig. 1 Monthly occurrence of Rotavirus diarrhea
Table 1 Age wise distribution of Rotavirus ELISA result
Age group
(months)
Positive Result Negative Result Total
0–12 92 (56.1%) 249 341
13–24 45(27.5%) 157 202
25–36 14(8.5%) 69 83
37–48 8(4.8%) 43 51
49–60 5(3.05%) 35 40
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In the study overriding Rotavirus infections was
observed in 1 year’s age group accounting 56.0% of
total Rotavirus positive samples (P value =0.03,<0.5).
In the group, most infections (34.2% of total) oc-
curred at the age of 7 to 12 months. And more than
80% of Rotavirus infections are found within the 2
years of age. Similarly, various studies have found that
most of Rotavirus infections occur within 2 years of
age, particularly after 7 months of age [19, 22–24].
Thus, vaccination at an early age can be beneficial to
prevent majority of cases of diseases.
Researches have shown that infant below 4 months of
age were initially protected to some extent by maternal
antibodies against severe rotavirus diarrhea, and breast
feeding as another independent factor preventing the
diarrhea, which can be a reason to have peak after
7 months [25, 26].
Rotavirus diarrhea is a disease of winter, recognized as
a winter gastroenteritis and vomiting but seasonality
may vary year to year [27]; in this study, peak in the
number of RVGE cases was observed between January
and March and marked the seasonal variation, with
peaks occurring in cooler and drier months of the year.
However, seasonal nature of Rotavirus is not universal,
and in countries within 10° of the equator, infection oc-
curred year round. Similar type of seasonal variation has
been reported by Uchida R et al. [20], Sherchand et al.
[13], Sherchan et al. [28] from studies done in Nepal.
Notably, in this study, the cases were found whole year
round; in contrast Uchida et al. [20] found no cases in
August and September and Sherchan [28] et al. did not
find any case of Rotavirus diarrhea in July.
Molecular analysis of Rotavirus genotypes revealed
that the predominant G type was G12 (36%) followed by
G9 (31%), G1 (21%) and G2 (8.6%). The predominance
of G 12 is in agreement with other studies as well, in a
3 year study by Sherchand et al. from November 2005 to
October 2008 in Nepal, G12 was predominant in all 3
years, 2005–2006 (50%), 2006–2007(29%), and 2007–
2008 (33.7%) [29]. In comparison to previous studies in
Nepal, there are subtle changes in the genotypes. In a
study by Ansari et al. (2013), G 12 (56%) was most
predominant followed by G2, G1 and G9 [19]. However,
in a study by Uchida et al. (2006) G1 was predominant,
followed by G 12 and G2. In current scenario, G12 is be-
ing regularly reported in high frequencies from South
East Asian countries-India, Bangladesh with conside-
rable diversity suggesting Ganges region can be its origin
from where it might have transmitted across the globe
[30–32]. Remarkably, we have reported 31% of G9,
higher percentage in comparison to previous studies in
Nepal. G9 was first reported from Philadelphia and after
1990s it has been found with increased frequency world-
wide, it has been reported from India, Brazil, Italy, the
United States, Bangladesh, Malawi, the United Kingdom,
France, and Australia [33, 34]. When the molecular
study of Rotavirus begun from 2003 in Nepal by Uchida
et al., in that first study G9 was not found, in subsequent
studies by Sherchand et al. and Ansari et al. there were
G9 genotypes occurrence comprising 2–6% [19, 20, 28].
Alike kind of increase in G9 has also been observed in
neighboring country India, from 2 to 10% in 2003–2007
to around 40% in 2013 [35]. The increment of G9 can
be because of the escape recognition by immune system
of Nepalese children where G 12 was predominant in
previous years. In spite of all, emerging unusual G12
genotype continues to be a predominant in our context
and circulating genotypes are within the cluster of G12,
G9, G1, G2 and G3 [11–13, 19, 20, 28].
Fig. 2 Gel run of G-type PCR showing Ladder (Lane 1), G2(Lane2),
G9(Lane3), G2(Lane4), G12(Lane5), G9(Lane6), G4(Lane7), UT(Lane8),
G2(Lane09), G2(Lane10), Negative control(Lane 11), G2(Lane 12) from
left to right.
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In this study the major P-type was P[6] (32.8%)
followed by P[8] (31%), P[10] (14.8%) and P[4] (14.8%),
previous studies also concordantly depicted either P[6]
or P[8] to be the leading one [11–13, 19, 20, 28]. P[6]
has been commonly detected from symptomatic infec-
tions as major genotype nowadays, although previously,
P[6] VP4 genotypes were detected from asymptomatic
infections only [36–38]. In the study P[10] was found
among less than one fourth of isolates in association
with G1, G2, G3, G9 and G10, although P[10] was not
reported before. The P-type (P[10]) as a unusual
serotype has also been reported from African countries
like Cameroon, Ghana, Libya [39].
The most common genotype combination in this study
is found to be G12P[6] (36%) followed by G1P[8]
(15.1%), G9P[8] (15.1%) G9P[4] (9.4%), G2P[4] (7.5%).
Comparing the Rotavirus genotype result from Nepal in
various studies, G12P[6] was found to be 12% in 2006
[20], 29% in 2011 [28], 46.4% in 2013 [19] and 36% in
this study showing prevailing characteristics of G12 P[6].
Although globally 5 G-P combinations (G1P[8], G2P[4],
G3P[8], G4P[8]) and G9P[8]) is responsible for approxi-
mately 90% of all human rotavirus infections; the
unusual serotypes of Rotavirus infections in our context
is anticipated. It has been described that unusual G and
P combinations constitute more than 14% of reported
rotavirus isolates from Asia, 27% from Africa, 11% from
South America, 5% from North America, 1.4% from
Europe, and 0.1% from Australia [40]. Unlike developed
countries where one or two genotypes predominate in a
season [41], large number of genotype combinations
along with unusual genotypes are comprehended in our
study. Mixed Rotavirus infection was observed in 7.5%.
G 1/G 12, P[4]/P[6] and P[4]/P[8] are the pattern of
mixed infections in this study.
The percentage of G1 P[8] was decreasing constantly
from 70% in 2006 [20] to 19% in 2011 [40] and 2.2% in
2013 [19]. Epidemiological and molecular studies in
many countries show complex patterns of change from
1 year to the next of Rotavirus serotypes associated with
diarrhea from the same geographical areas [42].
The Rotavirus vaccination has not been incorporated
in the national immunization schedule in Nepal.
However, there are instances of immunization on the
advice of clinician. Because of high burden of Rotavirus
gastroenteritis the necessity of vaccination can be appre-
ciated. The steep decrease in burden of diarrhea after
implementation of vaccination program can be expected
from the experience of countries like USA, Finland,
Belgium, Brazil, Venezuela, Mexico where Rotavirus
vaccination has been adopted. The reduction of all cause
diarrhea hospitalizations is larger in less than 1 year old
(35.6%) compared to one to 4 year old children (12.3%)
as noted in the study by Gurgel et al. [43].
Conclusion
Rotavirus diarrhea is, mostly affecting children from 7 to
24 months in Nepal, mostly occurring in winter. The
circulating genotypes in the country are found to be pri-
marily unusual genotypes and predominance of G12P[6].
It is recommended to conduct genotyping of Rotavirus on
large samples before starting vaccination in the country.
Additional file
Additional file 1: The data generated during the study. It includes the
data generated like age/sex, month of hospital visit, number of diarrhea
and vomiting in excel sheet. (XLSX 50 kb)
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